Antimicrobial Susceptibility Testing of the Combination of Aztreonam and Avibactam in NDM-Producing Enterobacterales: A Comparative Evaluation Using the CLSI and EUCAST Methods
Antibiotics · 03.07.2025 · 14 (7) · 675
DOI: 10.3390/antibiotics14070675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 03.07.2025. Verfasst von Linda Mei-Wah Chan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong SAR, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: bioMérieux, payment/honorarium for academic events from GKS, Pfizer.
Abstract (Originalsprache)
Background
The combination of aztreonam (ATM) and avibactam (AVI) presents an important therapeutic option for carbapenem-resistant Enterobacterales, particularly the NDM-producing Enterobacterales. In 2024, both the CLSI and EUCAST published their methods in antimicrobial susceptibility testing for this combination of agents. Materials and Methods: Forty carbapenem-resistant Enterobacterales isolates, including Escherichia coli (n = 35), Enterobacter cloacae complex (n = 2), Klebsiella pneumoniae complex (n = 2), and Citrobacter freundii complex (n = 1) were included in this study. All isolates harbored the NDM carbapenemase except one, which had no known detected carbapenemases. Four antimicrobial susceptibility testing methods of the combination of ATM and AVI were evaluated on these isolates, including the CLSI broth disk elution (BDE) method, the disk diffusion (DD) method of aztreonam–avibactam (AZA) following the EUCAST breakpoints, the MIC test strip (MTS) method of AZA following the EUCAST breakpoints, and the gradient strip stacking (SS) method. BDE was used as the standard of comparison.
Results
Using BDE as the standard of comparison, the AZA DD, AZA MTS, and SS methods had 100% categorical agreement (CA), 0% very major error (VME), and 0% major error (ME). The essential agreement (EA) between the AZA MTS and SS method was 57.5%.
Conclusions
The AZA DD, AZA MTS, and the SS methods showed complete concordance with the BDE method. However, the MICs obtained from the AZA MTS and SS were not comparable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong SAR, China.
- Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Linda Mei-Wah Chan, River Chun Wai Wong, Christopher Koon-Chi Lai
Förderung
- bioMérieux
- payment/honorarium for academic events from GKS
- Pfizer
Zitieren
APA
Chan, L. M., Lok, D. Y. L., Wong, R. C. W., Lee, A. L., Cheung, I. Y., Lai, C. K., & Chow, V. C. Y. (2025). Antimicrobial Susceptibility Testing of the Combination of Aztreonam and Avibactam in NDM-Producing Enterobacterales: A Comparative Evaluation Using the CLSI and EUCAST Methods. Antibiotics, 14(7), 675. https://doi.org/10.3390/antibiotics14070675
Vancouver
Chan LM, Lok DYL, Wong RCW, Lee AL, Cheung IY, Lai CK, et al. Antimicrobial Susceptibility Testing of the Combination of Aztreonam and Avibactam in NDM-Producing Enterobacterales: A Comparative Evaluation Using the CLSI and EUCAST Methods. Antibiotics. 2025;14(7):675. doi:10.3390/antibiotics14070675
BibTeX
@article{Chan2025,
author = {Chan, Linda Mei-Wah and Lok, Doris Yui Ling and Wong, River Chun Wai and Lee, Alfred Lok-Hang and Cheung, Ingrid Yu-Ying and Lai, Christopher Koon-Chi and Chow, Viola C Y},
title = {Antimicrobial Susceptibility Testing of the Combination of Aztreonam and Avibactam in NDM-Producing Enterobacterales: A Comparative Evaluation Using the CLSI and EUCAST Methods},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {7},
pages = {675},
doi = {10.3390/antibiotics14070675}
}
EUVIMED